Use of Anticancer Therapies and Economic Burden Near the End of Life in Japan: Results From Claims Database
PURPOSEIn patients with cancer, aggressive treatment near the end of life (EOL) may decrease quality of life and increase medical costs. In this study, we examined the use of anticancer therapies near the EOL in Japan.METHODSWe used a commercial database of health insurance claims in Japan, to exami...
Main Authors: | Yusuke Kajimoto, Kazunori Honda, Kazuki Nozawa, Mineko Mukai, Lida Teng, Ataru Igarashi |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2022-11-01
|
Series: | JCO Global Oncology |
Online Access: | https://ascopubs.org/doi/10.1200/GO.22.00227 |
Similar Items
-
Family caregiving in dementia and its impact on quality of life and economic burden in Japan-web based survey
by: Ataru Igarashi, et al.
Published: (2020-01-01) -
Burden of illness associated with pneumococcal infections in Japan - a targeted literature review
by: Ataru Igarashi, et al.
Published: (2022-12-01) -
Real‐world burden and treatment of chronic rhinosinusitis in Japan: A retrospective claims database analysis
by: Mamoru Yoshikawa, et al.
Published: (2023-04-01) -
Prevalence of multimorbidity and its associations with hospitalisation or death in Japan 2014–2019: a retrospective cohort study using nationwide medical claims data in the middle-aged generation
by: Takeo Nakayama, et al.
Published: (2023-05-01) -
Potential drug‐induced constipation: A retrospective study using a Japanese claims database
by: Yusuke Karasawa, et al.
Published: (2024-02-01)